SSGJ-707, A PD-1/VEGF BISPECIFIC ANTIBODY, COMBINED WITH PLATINUM-BASED CHEMOTHERAPY IN FIRST-LINE TREATMENT OF ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC): RESULTS FROM A PHASE 2 STUDY

Category Primary study
Conference40th Annual Meeting of Society for Immunotherapy of Cancer, SITC 2025
Year 2025
This article has no abstract
Epistemonikos ID: 61c9cae68c48476efbe74af5b7c4acd10a2fa014
First added on: Nov 28, 2025